DURATA THERAPEUTICS INC's ticker is DRTX and the CUSIP is 26658A107. A total of 71 filers reported holding DURATA THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 4.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $447,000 | – | 26,228 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners VII LLC | 1,902,030 | $24,118,000 | 41.13% |
| Aisling Capital LLC | 2,030,175 | $25,740,000 | 4.99% |
| EAM Investors, LLC | 187,925 | $2,383,000 | 0.48% |
| Granahan Investment Management | 691,283 | $8,765,000 | 0.27% |
| Orbimed Advisors | 1,785,714 | $22,643,000 | 0.24% |
| Lenox Wealth Advisors, LLC | 11,000 | $139,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 76,150 | $966,000 | 0.02% |
| PDT Partners, LLC | 61,331 | $778,000 | 0.02% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 5,022 | $63,000 | 0.02% |
| MASON STREET ADVISORS, LLC | 148,533 | $1,883,000 | 0.02% |